Development and application of indicators for the reduction of potentially preventable hospital admissions related to medications

Bibliography

• Beijer HJ, de Blaey CJ. Hospitalisations caused by advers drug reactions (ADR): a meta analysis of observational studies. Pharm World Sci 2002;24(2):46-54
   PubMed Web of Science ®Google Scholar
• Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J ClinPharmacol 2007;63:136-47
   PubMed Web of Science ®Google Scholar
• Benitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older american. N Engl Med 2011;365:2002-12
   PubMed Web of Science ®Google Scholar
• Sturkenboom MCJM, Dieleman JP. Ziekenhuisopnames door bijwerkingen van geneesmiddelen- een inventarisatie. Eindrapport. ErasmusMC; Rotterdam: 2006
   Google Scholar
• van der Hooft CS, Dieleman JP, Siemes C, et al. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 2008;17(4):365-71
   PubMed Web of Science ®Google Scholar
• Leendertse AJ, Egberts AC, Stoker LJ, Van den Bemt PMLA. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168(17):1890-6
   PubMed Web of Science ®Google Scholar
• Van den Bemt PMLA, Egberts ACG, Leendertse A. Hospital Admissions Related to Medication (HARM). Een prospectief, multicenter onderzoek naar geneesmiddel gerelateerde ziekenhuisopnames. Eindrapport. 2006
   Google Scholar
• Warle-van Herwaarden MF, Kramers C, Sturkenboom MC, et al. Targeting outpatient drug safety: recommendations of the Dutch HARM-wrestling task force. Drug Saf 2012;35(3):245-59
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Hasford J, Gottler M, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002;58(4):285-91
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329(7456):15-19
   PubMed Web of Science ®Google Scholar
• Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011;89(6):845-54
   PubMed Web of Science ®Google Scholar
• Morris CJ, Rodger S, Hammersley VS, et al. Indicators for preventable drug related morbidity: application in primary care. Qual Saf Health Care 2004;13(3):181-5
   PubMed Web of Science ®Google Scholar
• Tully MP, Cantrill JA. The validity of explicit indicators of prescribing appropriateness. Int J Qual Health Care 2006;18(2):87-94
   PubMed Web of Science ®Google Scholar
• Rhydderch M, Edwards A, Elwyn G, et al. Organizational assessment in general practice: a systematic review and implications for quality improvement. J Eval Clin Pract 2005;11(4):366-78
   PubMed Web of Science ®Google Scholar
• IPCI-2e International Classification of Primary Care 2nd edition, electronic version (previously called ICPC-2-E). [second edition]. Trondheim, The Norwegian Dictorate of Health [online]. Available from: http://www.kith.no/templates/kith_WebPage____1062.aspx [Last accessed July 2011]
   Google Scholar
• Lamberts H, Wood M, Hofmans-Okkes IM. International primary care classifications: the effect of fifteen years of evolution. Fam Pract 1992;9(3):330-9
   PubMed Web of Science ®Google Scholar
• WHO collaborating Centre for Drug Statistics Methodology. Oslo, Norwegian Institute of Public Health [online]. Available from: http://www.whocc.no/ [Last accessed 28 December 2011]
   Google Scholar
• Van der Lei J, Duisterhout JS, Westerhof HP, et al. The introduction of computer-based patient records in The Netherlands. Ann Intern Med 1993;119(10):1036-41
   PubMed Web of Science ®Google Scholar
• Vlug AE, Van der Lei J, Mosseveld BM, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999;38(4-5):339-45
   PubMed Web of Science ®Google Scholar
• Stichting Farmaceutische Kengetallen. The Hague, The Netherlands, Foundation for Pharmaceutical Statistics [online]. Available from: http://www.sfk.nl/english [Last accessed January 2012]
   Google Scholar
• Salvi F, Marchetti A, D'Angelo F, et al. Adverse drug events as a cause of hospitalization in older adults. Drug Safe 2012;35(Suppl 1):29-45
   PubMedGoogle Scholar
• Curtain CM, Bindoff IK, Westbury JL, Peterson GM. A comparison of prescribing criteria when applied to older community-based patients. Drug Aging 2013;30:11-935-43
   Google Scholar
• Thomsen LA, Winterstein AG, Søndergaard B, et al. Systematic review of the incidence and characteristics of preventable Adverse Drug Events in Ambulatory Care. Ann Pharmacother 2007;41(9):1411-26
   PubMed Web of Science ®Google Scholar
• Dormann H, Sonst A, Müller F, et al. Adverse drug events in older patients admitted as an emergency: the role of potentially inappropriate medication in elderly people (PRISCUS). DtschArztebl Int 2013;110(13):213-19
   Google Scholar
• De Smet PA. Hospital admissions related to medications and implementing guidelines. Arch Intern Med 2009;169(8):810-11
   PubMed Web of Science ®Google Scholar
• Helsper CW, Smeets HM, Numans ME, et al. Trends and determinants of adequate gastroprotection in patients chronically using NSAIDs. Pharmacoepidemiol Drug Saf 2009;18(9):800-6
   PubMed Web of Science ®Google Scholar
• Valkhoff VE, Van Soest EM, Sturkenboom MC, Kuipers EJ. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs). Aliment Pharmacol Ther 2010;31(11):1218-28
   PubMed Web of Science ®Google Scholar
• Bootsma JE, Warle-van Herwaarden MF, Verbeek AL, et al. Adherence to biochemical monitoring recommendations in patients starting with renin angiotensin system inhibitors: a retrospective cohort study in the Netherlands. Drug Saf 2011;34(7):605-14
   PubMed Web of Science ®Google Scholar
• McDowell SE, Coleman JJ, Evans SJ, et al. Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care. Pharmacoepidemiol Drug Saf 2010;19(5):482-9
   PubMed Web of Science ®Google Scholar
• Raebel MA, McClure DL, Simon SR, et al. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf 2007;16(1):55-64
   PubMed Web of Science ®Google Scholar
• Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012;379(9823):1310-19
   PubMed Web of Science ®Google Scholar